Straumann Holding AG Retained Earnings (Accumulated Deficit) 2012-2024 | SAUHY

Straumann Holding AG retained earnings (accumulated deficit) from 2012 to 2024. Retained earnings (accumulated deficit) can be defined as profits reinvested in the corporation after dividends have been paid out.
  • Straumann Holding AG retained earnings (accumulated deficit) for the quarter ending December 31, 2024 were $2.940B, a 65.07% increase year-over-year.
  • Straumann Holding AG retained earnings (accumulated deficit) for 2024 were $2.94B, a 14.12% increase from 2023.
  • Straumann Holding AG retained earnings (accumulated deficit) for 2023 were $2.576B, a 10.58% increase from 2022.
  • Straumann Holding AG retained earnings (accumulated deficit) for 2022 were $2.33B, a 15.48% increase from 2021.
Straumann Holding AG Annual Retained Earnings (Accumulated Deficit)
(Millions of US $)
2024 $2,940
2023 $2,576
2022 $2,330
2021 $2,017
2020 $1,639
2019 $1,566
2018 $1,387
2017 $1,169
2016 $642
2015 $762
2014 $938
2013 $816
2012 $781
2011 $824
Straumann Holding AG Quarterly Retained Earnings (Accumulated Deficit)
(Millions of US $)
2024-12-31 $2,940
2023-12-31 $2,576
2022-12-31 $2,330
2021-12-31 $2,017
2021-06-30 $1,781
2020-12-31 $1,639
2020-06-30 $1,403
2019-12-31 $1,566
2018-12-31 $1,387
2017-12-31 $1,169
2017-06-30 $941
2016-12-31 $642
2016-06-30 $836
2015-12-31 $762
2014-12-31 $938
2013-12-31 $816
2013-06-30 $750
2012-12-31 $781
2012-06-30 $789
2011-12-31 $824
Sector Industry Market Cap Revenue
Medical Medical & Dental Supplies $19.980B $2.845B
The Straumann Group is a global leader in implant and restorative dentistry and oral tissue regeneration. In collaboration with leading clinics, research institutes and universities, Straumann researches, develops and manufactures dental implants, instruments, prosthetics and tissue regeneration products for use in tooth replacement and restoration solutions or to prevent tooth loss. Straumann currently employs approximately on thousand seven hundred ninety people worldwide and its products and services are available in more than sixty countries through its broad network of distribution subsidiaries and partners.
Stock Name Country Market Cap PE Ratio
McKesson (MCK) United States $90.196B 21.78
Becton Dickinson (BDX) United States $48.270B 11.95
Cardinal Health (CAH) United States $39.000B 20.42
West Pharmaceutical Services (WST) United States $15.506B 32.50
Cooper (COO) United States $13.893B 17.90
Align Technology (ALGN) United States $13.177B 26.16
Henry Schein (HSIC) United States $8.761B 15.03
Merit Medical Systems (MMSI) United States $5.436B 26.28
DENTSPLY SIRONA (XRAY) United States $3.061B 9.14
CONMED (CNMD) United States $1.615B 12.08
STAAR Surgical (STAA) United States $0.809B 0.00
Lifevantage (LFVN) United States $0.158B 16.27
Pro-Dex (PDEX) United States $0.132B 14.48